LARIMAR THERAPEUTICS, INC.
Profile
Company Names
LARIMAR THERAPEUTICS, INC.
ZAFGEN, INC.
Addresses
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA 19004
ONE BROADWAY, 8TH FLOOR, CAMBRIDGE, MA 02142
ONE BROADWAY, 8TH FLOOR, CAMBRIDGE, MA 02142
1 CAMBRIDGE CENTER, SUITE 702, CAMBRIDGE, MA 02142
5 CAMBRIDGE CENTER, FLOOR 2, CAMBRIDGE, MA 02142
Phone Numbers
844-511-9056
(617 ) 401-3051
(617 ) 864-1645
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER HEALTH CARE
Year Incorporated:
2005
State Incorporated:
DELAWARE
Total Amount Raised:
$201,027,096.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2020-05-29
$80,000,000.00
$80,000,000.00
$0.00
Equity
5
2020-05-28
$82,079,593.00
$82,079,593.00
$0.00
Equity
4
2012-11-30
$21,761,570.00
INDEFINITE
INDEFINITE
Equity
3
2012-08-13
$3,000,000.00
INDEFINITE
INDEFINITE
Debt
2
2011-06-30
$6,085,933.00
INDEFINITE
INDEFINITE
Equity
1
2010-02-17
$8,100,000.00
$10,125,000.00
$2,025,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER
BARRETT
DIRECTOR
VITAE PHARMACEUTICALS, INC
| HELICOS BIOSCIENCES CORP
| SIRION HOLDINGS, INC.
| ZAFGEN, INC.
| MOLECULAR BIOMETRICS INC
| STROMEDIX INC
| INFACARE PHARMACEUTICAL CORP
| JENAVALVE TECHNOLOGY INC
| MNEMOSYNE PHARMACEUTICALS INC
| SYNLOGIC, INC.
| PLAYGROUND VENTURES, L.P.
| PLAYGROUND GLOBAL, LLC
| SUBPAC, INC.
| SYNLOGIC, LLC
| INDALO THERAPEUTICS, INC.
| BINGHAM NATURAL WINES, LLC
| OBSIDIAN THERAPEUTICS, INC.
| SYNLOGIC, INC.
| LARIMAR THERAPEUTICS, INC.
| PLAYGROUND COMPUTE, L.P.
| ARTIFICIAL, INC.
| ANJUNA SECURITY, INC.
| MOSAIC ML, INC.
| PERKINELMER INC
| PLAYGROUND ACQUIRE, L.P.
| PLAYGROUND OMEGA, L.P.
| PLAYGROUND HELIX, L.P.
| PSIQUANTUM, CORP.
| PLAYGROUND OMEGA 2, L.P.
| XLIGHT INC.
| PLAYGROUND GENESIS, L.P.
| PLAYGROUND VENTURES IV, L.P.
| PLAYGROUND VENTURES AFFILIATES IV, L.P.
MITCHELL
BLOOM
EXECUTIVE OFFICER
MITCHELL
S.
BLOOM
EXECUTIVE OFFICER
BRUCE
BOOTH
DIRECTOR
MIRAGEN THERAPEUTICS INC
| AVILA THERAPEUTICS INC
| ZAFGEN, INC.
| NIMBUS DISCOVERY, LLC
| ON-Q-ITY, INC.
| NUMERATE INC
| UNUM THERAPEUTICS, INC.
| LYSOSOMAL THERAPEUTICS, INC.
| AVROBIO, INC.
| MAGENTA THERAPEUTICS, INC.
| ATLAS VENTURE FUND XI, L.P.
| RODIN THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| ATLAS VENTURE FUND XII, L.P.
| VIGIL NEUROSCIENCE, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| MATCHPOINT THERAPEUTICS INC.
| ATLAS VENTURE FUND XIV, L.P.
| ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
THOMAS
HUGHES
EXECUTIVE OFFICER, DIRECTOR
JONATHAN
LEFF
DIRECTOR
HANA BIOSCIENCES INC
| RIB X PHARMACEUTICALS INC
| TALON THERAPEUTICS, INC.
| N30 PHARMACEUTICALS, INC.
| AUDENTES THERAPEUTICS, INC.
| AVEXIS, INC.
| APRECIA PHARMACEUTICALS CO
| PROTEON THERAPEUTICS INC
| DRACEN PHARMACEUTICALS, INC.
| ARS PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC
| LARIMAR THERAPEUTICS, INC.
| AVALYN PHARMA INC.
| AEROVATE THERAPEUTICS, INC.
| ADAPTIVE PHAGE THERAPEUTICS, INC.
| INNERVACE, INC.
| BIOMX INC.
| ELION THERAPEUTICS, INC.
| AXONIS THERAPEUTICS, INC.
KEVIN
STARR
DIRECTOR
LOU
TARTAGLIA
DIRECTOR
LOUIS
TARTAGLIA
DIRECTOR
FRANK
E.
THOMAS
DIRECTOR
JOSEPH
TRUITT
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-05-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-05-28
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MTS PARTNERS
NONE

